Statistically significant differences were observed in factors such as age, CEA, WBC count, albumin level, time of GC surgery, tumor size, postoperative metastasis, nerve invasion, and the interval from gastrectomy to first SBO (p < 0.05). The gene discussed is CEACAM5; the disease is neoplasm.